Natural Alternatives International Inc 最近的每股盈餘為 $, $ 的預期。
Natural Alternatives International Inc NAII 上一季度的收入表現如何?
Natural Alternatives International Inc 上一季度的收入為 $
Natural Alternatives International Inc 的收入預期是多少?
根據 位華爾街分析師的預測,Natural Alternatives International Inc 的收入預期範圍從 $ 到 $
Natural Alternatives International Inc 的盈利品質評分是多少?
Natural Alternatives International Inc 的盈利品質評分為 B/41.72726。該評分基於盈利能力、增長、現金生成與資本分配以及槓桿四個維度。
Natural Alternatives International Inc 何時發布財報?
Natural Alternatives International Inc 的下一份財報預計在 2026-05-18 發布
Natural Alternatives International Inc 的預期收益是多少?
根據華爾街分析師的預測,Natural Alternatives International Inc 的預期收益為 $
Natural Alternatives International Inc 是否超出收益預期?
Natural Alternatives International Inc 最近的收益為 $, 預期。
關鍵數據
前收市價
$2.56
開盤價
$2.53
當日範圍
$2.5 - $2.61
52週區間
$2.33 - $4.96
交易量
10.0K
平均成交量
22.1K
股息收益率
--
每股盈餘 (TTM)
-2.43
市值
$16.0M
什麼是 NAII?
Natural Alternatives International, Inc. engages in the manufacturing, distribution, and marketing of nutritional supplements and other health care products. The company is headquartered in Carlsbad, California and currently employs 293 full-time employees. Its primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the United States. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. The company manufactures products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of its customer's preferences. The company also seeks to commercialize its patent and trademarks through the direct distribution and sale of CarnoSyn, SR CarnoSyn, TriBsyn, new contract manufacturing opportunities, and various license, royalty, and similar arrangements.